Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

novartis pharma k.k. - indacaterol acetate; glycopyrronium bromide; mometasone furoate - green transparent/colorless and transparent inhalation capsule, major axis: 16.0 mm, minor axis: 5.8 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

novartis pharma k.k. - indacaterol acetate; glycopyrronium bromide; mometasone furoate - green transparent/colorless and transparent inhalation capsule, major axis: 16.0 mm, minor axis: 5.8 mm

Canada - English - Health Canada

novartis pharmaceuticals canada inc - indacaterol (indacaterol acetate); mometasone furoate - capsule - 150mcg; 80mcg - indacaterol (indacaterol acetate) 150mcg; mometasone furoate 80mcg - adrenals

Canada - English - Health Canada

novartis pharmaceuticals canada inc - indacaterol (indacaterol acetate); mometasone furoate - capsule - 150mcg; 320mcg - indacaterol (indacaterol acetate) 150mcg; mometasone furoate 320mcg - adrenals

Canada - English - Health Canada

novartis pharmaceuticals canada inc - indacaterol (indacaterol acetate); mometasone furoate - capsule - 150mcg; 160mcg - indacaterol (indacaterol acetate) 150mcg; mometasone furoate 160mcg - adrenals

Israel - English - Ministry of Health

novartis israel ltd - indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 300 mcg - indacaterol - maintenance of bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (copd).

Canada - English - Health Canada

novartis pharmaceuticals canada inc - indacaterol (indacaterol maleate) - capsule - 75mcg - indacaterol (indacaterol maleate) 75mcg - selective beta 2-adrenergic agonists

Australia - English - Department of Health (Therapeutic Goods Administration)

grand medical pty ltd - indacaterol acetate, quantity: 173 microgram (equivalent: indacaterol, qty 150 microgram); mometasone furoate, quantity: 320 microgram - capsule, hard - excipient ingredients: lactose monohydrate - bemrist breezhaler is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older where use of a combination of long-acting beta2-agonist and inhaled corticosteroid is appropriate:,- patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists or,- patients not adequately controlled with long-acting beta2-agonists and low dose of inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

siegfried barbera s.l. - indacaterol (indacaterol acetate), mometasone fuorat - inhalation powder, capsules hard - 150mcg+ 320mcg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - indacaterol maleate - inhalation powder - 300microgram